Zusammenfassung
Das gedankliche Fundament der biochemischen Genetik verdanken wir Sir Archibald Garrod. Im ersten Jahrzehnt unseres Jahrhunderts formulierte Garrod das Konzept von den „inborn errors of metabolism“, eine Theorie, die nicht nur das Prinzip der genetischen Steuerung des Stoffwechsels vorwegnahm, sondern ausdrücklich auch die genetisch bedingte interindividuelle Variabilität auf der Ebene dessen, was wir heute als biochemische Merkmale bezeichnen würden. Garrod hat auch schon das breite Spektrum von Möglichkeiten diskutiert, das sich zwischen pathogenen Enzymdefekten einerseits und biochemischen Normvarianten andererseits ausspannt. Diesen gedanklichen Rahmen sehen wir heute mit einer stetig steigenden Wissensflut angefüllt, in der man sich nur noch anhand von Ordnungsprinzipien orientieren kann, die gleichwohl ihrerseits einem zeitlichen Wandel unterworfen sind. Als Ordnungsprinzipien bieten sich biochemische und genetische Zusammenhänge an. Die biochemische Systematik geht vom Genprodukt mit seinem meist pleiotropen Wirkungsspektrum aus. Die genetischen Ordnungsprinzipien beziehen sich demgegenüber auf die Natur der jeweiligen genetischen Veränderungen, also auf die Art, Lokalisation und Expression der jeweiligen Mutationsereignisse.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Bickel H (1980) Phenylketonuria: Past, present, future. J Inher Metab Dis 3: 123–132
Breathnach R, Chambon P (1981) Organization and expression of eukaryotic split genes. Annu Rev Biochem 50: 349–383
Conzelmann E, Sandhoff K (1978) AB variant of infantile GM2-gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalized degredation of ganglioside Gm2 and glycolipid GA2. Proc Natl Acad Sci USA 75: 3979–3983
De Noto FM, Moore DD, Goodman HM (1981) Human growth hormone DNA sequence and mRNA structure: possible alternative splicing.
Nucleic Acid Res 9: 3719–3730
Early P, Rogers J, Davis M, Calame K, Bond M, Wall R, Hood L (1980) Two mRNA can be produced from a single immunoglobulin µ gene by alternative RNA processing pathways. Cell 20: 313–319
Galjaard H, Hoogeven A, Keijzer W, DeWit-Verbeek E, Vlek-Noot E (1974) The use of quantitative cytochemical analysis in rapid prenatal detection and somatic cell genetic studies of metabolic diseases. Histochem J 6: 491–509
Hasilik A, Neufeld EF (1980) Biosynthesis of lysosomal enzymes in fibroblasts; phosphorylation of mannose residues. J Biol Chem 255: 4946–4950
Hösli P (1977) Quantitative assays of enzyme activity in single cells: Early prenatal diagnosis of genetic disorders. Clin Chem 23: 1476–1484
Krieg T, Ihme A, Weber L, Kirsch E, Mueller PK (1981) Molecular defects of collagen metabolism in the Ehlers-Danlos-Syndrome. Int J Dermatol 20: 415–425
Krone W, Wolf U (1978) Chromosomes and protein variation. In: Mayo O, Brock DJH (eds) The biochemical genetics of man. Academic Press, New York, pp 93–154
Maquat L, Kinniburgh AJ, Beach LR, Honig GR, Lazerson J, Ershler WB, Ross J (1980) Processing of human ß-globin mRNA precursor to mRNA is defective in three patients with ß+-thalassaemia. Proc Natl Acad Si USA 77: 4287–4291
McKusick VA (1978) Mendelian inheritance in man, 5th ed. John Hopkins Univ Press, Baltimore London
Mohandas T, Shapiro LJ, Sparkes RS, Sparkes MC (1979) Regional assignment of the steroid sulfatase X-linked ichthyosis locus: Implications for a non-inactivated region on the short arm of the human X-chromosome. Proc Natl Acad Sci USA 76: 5779–5783
Müller CR, Migl B, Traupe A, Ropers HH (1980) X-linked steroid sulfatase: Evidence for different gene dosage in males and females. Hum Genet 54: 197–199
Ruddle FH, Creagan RP (1975) Parasexual approaches to the genetics of man. Annu Rev Genet 9: 407–486
Wolf U, Fraccaro M, Mayerova A, Hecht T, Maraschio P, Hameister H (1980) A gene controlling H-Y antigen on the X-chromosome: tentative assignment by deletion mapping to Xp223. Hum Genet 54: 149–154
Wunder E, Burghardt U, Lang B, Hamilton L (1981) Fanconi’s anemia: Anomaly of enzyme passage through the nuclear membrane? Hum Genet 58: 149–155
Basu SK, Brown MS, Ho YK, Havel RJ, Goldstein JL (1981) Mouse macrophages synthesize and secret a protein resembling apolipoprotein E. Proc Natl Acad Sci USA 78: 7545
Boberg J, Augustin J, Baginsky ML, Tejeda P, Brown WV (1977) Quantitative determination of hepatic and lipoprotein lipase activities from human postheparin plasma. J Lipid Res 18: 544
Breckenridge WC, Little JA, Steiner G, Chow A, Poapst M (1978) Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. N Engl J Med 298: 1265
Brown MS, Goldstein JL (1976) Receptor-mediated control of cholesterol metabolism. Science 181: 150
Brown MS, Goldstein JL, Fredrickson DS (1982a) Familial type 3 hyperlipoproteinemia (dysbetalipoproteinemia). In: Stanbury JB, Wyngaarden JS, Fredrickson DS, Goldstein JL, Brown MS (eds) The metabolic basis of inherited disease. McGraw-Hill, New York (in press)
Brown MS, Goldstein JF (1982b) Personal communication
Franceschini G, Sirtori M, Gianfraneschi G, Sirtori CL (1981) Relation between the HDL apoproteins and A-I isoproteins in subjects with A-I Milano abnormality. Metabolism 30: 502
Fredrickson DS (1960) Essential familial hyperlipidemia. In: Stanbury JB, Wyngaarden JS, Fredrickson DS (eds) The metabolic basis of inherited disease. McGraw-Hill, New York, p 489
Fredrickson DS (1966) Familial high-density lipoprotein deficiency: Tangier disease. In: Stanbury JB, Wyngaarden JS, Fredrickson DS (eds) The — metabolic basis of inherited disease. McGraw-Hill, New York, p 486
Fredrickson DS, Altrocchi PH, Avioli LV, Goodman DS, Goodman HC (1961) Tangier disease. Ann Intern Med 55: 1016
Fredrickson DS, Lees RS (1966) Familial hyperlipoproteinemia. In: Stanbury JB, Wyngaarden JS, Fredrickson DS (eds) The metabolic basis of inherited disease. McGraw-Hill, New York, p 429
Fredrickson DS, Levy RI, Lees RS (1967) Fat transport in lipoproteins — an integrated approach to mechanisms and disorders. N Engl J Med 276: 32, 94, 148, 215, 273
Fredrickson DS, Morganroth J, Levy RI (1975) Type III hyperlipoproteinemia: analysis of two contemporary definitions. Ann Intern Med 82: 150
Fredrickson DS, Goldstein JL, Brown MS (1978) The familial hyperlipoproteinemias. In: Stanbury JB, Wyngaarden JS, Fredrickson DS (eds) The metabolic basis of inherited disease. McGraw-Hill, New York, p 604
Giselli G, Schaefer EJ, Gascon P, Brewer BH (1981) Type III hyperlipoproteinemia associated with apolipoprotein E deficiency. Science 214: 1239
Gjone E, Norum KR, Glomset JA (1978) Familial lecithin: cholesterol acyltransferase deficiency. In: Stanbury JB, Wyngaarden JS, Fredrickson DS (eds) The metabolic basis of inherited disease. McGraw-Hill, New York, chapter 29
Glomset JA (1968) The plasma lecithin: cholesterol acyltransferase reaction. J Lipid Res 9: 155
Gofman JW, Rubin L, McGinley JP, Jones HB (1954) Hyperlipoproteinemia. Am J Med 17: 514
Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG (1973) Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 52: 1544
Goldstein JL, Brown MS (1982) Familial hypercholesterolemia. In: Stanbury JB, Wyngaarden JS, Fredrickson DS, Goldstein JL, Brown MS (eds) The metabolic basis of inherited disease. McGraw-Hill, New York (in press)
Greten H, De Grella R, Klose G, Rascher W, DeJennes JL, Gjone E (1976) Measurement of two plasma triglyceride lipases by an immunochemical method: studies in patients with hypertriglyceridemia. J Lipid Res 17: 203
Havel RJ (1982) Familial dysbetalipoproteinemia: new aspects of pathogenesis and diagnosis. Med Clin N Amer 66
Havel RJ, Gordon RS Jr (1960) Idiopathic hyperlipemia: metabolic studies in an affected family. J Clin Invest 39: 1777
Havel RJ, Shore VG, Shore B, Biou DM (1970) Role of specific glycopeptides of human serum lipoproteins in the activation of lipoprotein lipase. Circ Res 27: 595
Havel RJ, Chao Y-S, Windler EE, Kotite L, Guo LS (1980) Isoprotein specificity in the hepatic uptake of apolipoprotein E and the pathogenesis of familial dysbetalipoproteinemia. Proc Natl Acad Sci USA 77: 4349
Herbert PH, Assmann G, Gotto AM, Fredrickson DS (1982) The familial hyperlipoproteinemias. In: Stanbury JB, Wyngaarden JS, Fredrickson DS, Goldstein JL, Brown MS (eds) The metabolic basis of inherited disease. McGraw-Hill, New York (in press)
Holt LE, Aylward FX, Timbres HG (1939) Idiopathic familial lipemia. Johns Hopkins Med J 64: 279
Huttunen JK, Enholm C, Kinnunen PKJ, Nikkila EA (1975) An immunochemical method for selective measurement of two triglyceride lipases in human posthepar plasma. Clin Chim Acta 63: 335
Kane JP, Hardman DA, Paulus HE (1980) Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons. Proc Natl Acad Sci USA 77: 2465
Kostner G (1974) Studies on the cofactor requirements for lecithin: cholesterol acyltransferase. Scand J Clin Lab Invest [Suppl 33] 137: 19
Kraus RM, Levy RI, Fredrickson DS (1977) Selective measurement of two lipase activities in post-heparin plasma from normal subjects and patients with hyperlipoproteinemia. J Clin Invest 54: 1107
Lamy M, Frezal J, Polonovski J, Rey J (1960) L’absence congenitale de beta-lipoproteines. C R Soc Biol (Paris) 154: 1974
LaRosa JC, Levy RI, Herbert P, Lux SE, Fredrickson DS (1970) A specific activator for lipoprotein lipase. Biochem Biophys Res Commun 41: 57
Mabry CC, DiGeorge AM, Auerbach VH (1960) Studies concerning the defect in a patient with acanthocytosis. Clin Res 8: 371
Mahley RW (1982) Atherogenic hyperlipoproteinemia: the cellular and molecular biology of plasma lipoproteins altered by dietary fat and cholesterol. Med Clin N Amer 66: 375
Mahley RW, Hui D, Innerarity TL, Weisgraber KH (1981) Two independent lipoprotein receptors on hepatic membranes of dog, swine, and man. J Clin Invest 68: 1197
Malloy MJ, Kane JP, Hardman DA, Hamiltor RL, Dalai KB (1981) Normotriglyceridemic abetalipoproteinemia: absence of the B-100 apolipoprotein. J Clin Invest 67: 1441
Menzel H-J, Kladetzky HG, Assmann G (1982) One-step screening method for the polymorphism of apolipoproteins A-I, A-II and A-IV. J Lipid Res (in press)
Muller C (1938) Xanthomata, hypercholesterolemia, angina pectoris. Acta Med Scand [Suppl] 89: 75
Nikkila EA (1982) Familial lipoprotein lipase deficiency and related disorders of chylomicron metabolism. In: Stanbury JB, Wyngaarden JS, Fredrickson DS, Goldstein JL, Brown MS (eds) The metabolic basis of inherited disease. McGraw-Hill, New York (in press)
Nikkila EA, Arp A (1973) Family study of serum lipids and lipoproteins in coronary heart disease. Lancet 1: 954
Rall SC Jr, Weisgraber KH, Mahley RW (1982a) Human apolipoprotein E: the complete amino acid sequence. J Biol Chem 257: 4171
Rall Sc Jr, Weisgraber KH, Innerarity TL, Mahley RW (1982b) Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects. Proc Natl Acad Sci USA (in press)
Rose HG, Kranz P, Weinstock M, Juliano J, Haft JI (1972) Inheritance of combined hyperlipoproteinemia: evidence from a new lipoprotein phenotype. Am J Med 54: 148
Salt
HB, Wolff OH, Lloyd JK, Fosbrooke AS, Cameron AH, Hubble DV (1960) On having no beta-lipoprotein: a syndrome comprising abetalipoproteinemia, acanthocytosis, and steatorrhea. Lancet 2: 325
Schneider WH, Kovanen PT, Brown MS, Goldstein JL, Utermann G, Weber W, Havel RJ, Kotite L, Kane JP, Innerarity TL, Mahley RW (1981) Familial dysbetalipoproteinemia: abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows. J Clin Invest 68: 1075
Shore VG, Shore B (1970) Isolation and characterization of human serum lipoproteins. Biochemistry 11: 4510
Tannhauser HJ, Magendetz H (1938) The different clinical groups of xanthomatous diseases: a clinical physiological study of 22 cases. Ann Intern Med 11: 1662
Utermann G, Haeschke M, Menzal J (1975) Familial hyperlipoproteinemia type III: deficiency of a specific apolipoprotein (apo E-III) in very low density lipoproteins. FEBS Lett 56: 352
Utermann G, Canzler H, Hees M, Jaeschke M, Muhlfellner G, Schoenborn W, Vogelberg KH (1977) Studies on the metabolic defect in broad-beta disease (hyperlipoproteinemia type III). Clin Genet 12: 139
Utermann G, Pruin N, Steinmetz A (1979) Polymorphism of apolipoprotein E.III: effect of a single polymorphic gene locus on plasma lipid levels in man. Clin Genet 15: 63
Utermann G, Hees M, Steinmetz A (1981a) Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinemia in man. Nature 269: 11
Utermann G, Steinmetz A, Haas J, Feusner G, Franceschini G (1981b) Apolipoproteinopathies: rapid method for screening and characterization of genetic apolipoprotein A variants. J Biol Chem (in press)
Weisgraber KH, Rall SC Jr, Mahley RW (1981) Human E apoprotein heterogeneity: cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J Biol Chem 256: 9077
Weisgraber KH, Innerarity TL, Mahley RW (1982) Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J Biol Chem 257: 2518
Zannis VI, Breslow JL (1981a) Human very low density lipoprotein apolipoprotein A isoprotein polymorphism is explained by genetic variation and post-translational modification. Biochemistry 20: 1033
Zannis VI, Just PW, Breslow JL (1981b) Human apolipoprotein E isoprotein subclasses are genetically determined. Am J Hum Genet 33: 11
Hers HG, Van Hoof F (1973) Lysosomes and storage diseases. Academic Press, New York London
Nausieda PA, Klawans HL (1977) Lipid storage disorders. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology, vol 29. Metabolic and deficiency diseases of the nervous system, part III. North Holland Publ. Comp., Amsterdam New York Oxford, pp 345–390
Seitelberger et al. (1957) Spätinfantile amaurotische Idiotie. Arch Psychiatr Nervenkr 196: 154–190
Seitelberger F (1964) Über die Gehirnbeteiligung bei der Gaucherschen Krankheit im Kindesalter. Arch Psychiatr Nervenkr 206: 419–440
Seitelberger F, Bernheimer H (1968) Über das Verhalten der Ganglioside im Gehirn bei 2 Fällen von spätinfantiler amaurotischer Idiotie. Wien Klin Wochenschr 80: 163–164
Stanbury JB, Wyngaarden JB, Fredrickson DS (1978) The metabolic basis of inherited disease. McGraw Hill Book Comp.
Kelley WN, Wyngaarden JB (1982) Clinical syndromes associated with hypoxanthine-guanine phosphoribosyltransferase deficiency. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds) Metabolic basis of inherited disease, 5th ed. McGraw-Hill, New York, p 1115
Seegmiller JE, Rosenbloom FM, Kelley WN (1967) An enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis. Science 155: 1682
Lesch M (1970) The — purine revolution. N Engl J Med 28: 1221
Wyngaarden JB, Kelley WN (1982) Gout. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds) Metabolic basis of inherited disease, 5th ed. McGraw-Hill, p 1043
Sperling O, Persky-Brosh S, Boer P, De Vries A (1973) Human erythrocyte phosphoribosylpyrophosphate synthetase mutationally altered in regulatory properties. Biochem Med 7: 389
Holmes EW, Wyngaarden JB (1982) Hereditary xanthinuria. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds) Metabolic basis of inherited disease, 5th ed. McGraw-Hill, New York, p 1192
Simmonds HA, Van Acker KJ (1982) Adenine phosphoribosyltransferase deficiency: 2,8-dihydroxyadenine lithiasis. In: Stanbury TB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds) Metabolic basis of inherited disease, 5th ed. McGraw-Hill, New York, p 1144
Swain JL, Sabina RL, Holmes EW (1982) Myoadenylate deaminase deficiency. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds) Metabolic basis of inherited disease, 5th. ed. McGraw-Hill, New York, p 1184
Fishbein WN, Armbrustmacher VW, Griffin JL (1978) Myoadenylate deaminase deficiency: A new disease of muscle. Science 200: 545
Sabina RL, Swain JL, Patten BM, Ashizawa T, O’Brien W, Holmes EW (1980) Disruption of the purine nucleotide cycle: A potential explanation for muscle dysfunction in myoadenylate deaminase deficiency. J Clin Invest 66: 1419
Kredich NM, Hershfield MS (1982) Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds) Metabolic basis of inherited disease, 5th ed. McGraw-Hill, New York, p 1158
Hers H-G, Van den Berghe G (1979) Enzyme defect in primary gout. Lancet 1: 585
Van den Berghe G, Hers H-G (1980) Abnormal AMP deaminase in primary out. Lancet 2: 1090
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Krone, W. et al. (1982). Symposium Genetik der angeborenen Stoffwechselstörungen. In: Schlegel, B. (eds) Verhandlungen der Deutschen Gesellschaft für innere Medizin. Verhandlungen der Deutschen Gesellschaft für innere Medizin, vol 88. J.F. Bergmann-Verlag, Munich. https://doi.org/10.1007/978-3-642-47093-6_27
Download citation
DOI: https://doi.org/10.1007/978-3-642-47093-6_27
Publisher Name: J.F. Bergmann-Verlag, Munich
Print ISBN: 978-3-8070-0332-0
Online ISBN: 978-3-642-47093-6
eBook Packages: Springer Book Archive